VOR
Vor Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.04
+0.06%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 35.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.33x
- Price / sales
- —
- Price / cash flow
- -7.60x
Enterprise value
- Enterprise value
- $604.0M
- EV / sales
- —
- EV / EBITDA
- 0.94x
- EV / EBIT
- -4.11x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026